Skip to main content
SpringerLink
Log in

Patient Management

  • Chapter
  • First Online:
Medical Treatment of Glaucoma

  • 635 Accesses

Abstract

Glaucoma care is a great challenge. Our aim as caregivers is, often with limited resources, to provide lifelong care to an ever-increasing number of patients suffering from a vision-threatening disease. To achieve this, we not only need to mobilize the available resources in the healthcare system but also must cooperate with our patients. Furthermore, we should discuss the importance of glaucoma care with policy makers and healthcare payers so that adequate resources are allocated to glaucoma care. Patient-centered cost-effective glaucoma management should be carried out at both the individual level and at group levels, covering those patients yet to be diagnosed. At present, elevated intraocular pressure (IOP) is the only factor we can modify in our daily clinical practice. However, our care should not be limited to this. We should bear in mind throughout the care process that our goal is to ensure a good quality of life for glaucoma patients at a sustainable cost. This chapter discusses the glaucoma care process at different stages of the disease, from early detection to low-vision rehabilitation. We feel that it is essential to establish a good cooperation with the patient, and ensure that the patient understands the importance of glaucoma treatment and adheres to the treatment regimen. This chapter ends with a brief discussion on “big data” analysis. Big data analysis with standardized criteria for diagnosing different types of glaucoma, well-defined patient-related outcome measures, and relevant hypotheses may provide us with insight into key areas of interest, such as vision-related quality of life, care quality, and effectiveness of treatment regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sima Q. (145-86 BCE). Records of Grand Historian.

    Google Scholar 

  2. Forsman E, Kivela T, Vesti E. Lifetime visual disability in open-angle glaucoma and ocular hypertension. J Glaucoma. 2007;16(3):313–9.

    Article  PubMed  Google Scholar 

  3. Peters D, Bengtsson B, Heijl A. Lifetime risk of blindness in open-angle glaucoma. Am J Ophthalmol. 2013;156(4):724–30.

    Article  PubMed  Google Scholar 

  4. Burr JM, Mowatt G, Hernandez R, Siddiqui MA, Cook J, Lourenco T, Ramsay C, Vale L, Fraser C, Azuara-Blanco A, Deeks J, Cairns J, Wormald R, McPherson S, Rabindranath K, Grant A. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess. 2007;11(41):iii–v.. ix–x, 1–190

    Article  CAS  PubMed  Google Scholar 

  5. Hernandez RA, Burr JM, Vale LD, OAG Screening Project Group. Economic evaluation of screening for open-angle glaucoma. Int J Technol Assess Health Care. 2008;24(2):203–11.

    Article  PubMed  Google Scholar 

  6. Quigley HA, Park CK, Tracey PA, Pollack IP. Community screening for eye disease by laypersons: the Hoffberger program. Am J Ophthalmol. 2002;133(3):386–92.

    Article  PubMed  Google Scholar 

  7. Tielsch JM, Katz J, Singh K, Quigley HA, Gottsch JD, Javitt J, Sommer A. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol. 1991;134(10):1102–10.

    Article  CAS  PubMed  Google Scholar 

  8. Tuulonen A. Cost-effectiveness of screening for open angle glaucoma in developed countries. Indian J Ophthalmol. 2011;59(Suppl):S24–30.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kyari F, Abdull MM, Bastawrous A, Gilbert CE, Faal H. Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors. Middle East Afr J Ophthalmol. 2013;20(2):111–25.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Boland MV, Gupta P, Ko F, Zhao D, Guallar E, Friedman DS. Evaluation of frequency-doubling technology perimetry as a means of screening for glaucoma and other eye diseases using the National Health and Nutrition Examination Survey. JAMA Ophthalmol. 2016;134(1):57–62.

    Article  PubMed  Google Scholar 

  11. Chan MPY, Broadway DC, Khawaja AP, Yip JLY, Garway-Heath DF, Burr JM, Luben R, Hayat S, Dalzell N, Khaw KT, Foster PJ. Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study. BMJ. 2017;358:j3889.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology. 1999;106(11):2144–53.

    Article  CAS  PubMed  Google Scholar 

  13. Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology. 1997;104(4):712–8.

    Article  CAS  PubMed  Google Scholar 

  14. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;266(3):369–74.

    Article  CAS  PubMed  Google Scholar 

  15. Geimer SA. Glaucoma diagnostics. Acta Ophthalmol. 2013;91(1):1–32.

    Article  PubMed  Google Scholar 

  16. Fallon M, Valero O, Pazos M, Anton A. Diagnostic accuracy of imaging devices in glaucoma: a meta-analysis. Surv Ophthalmol. 2017;62(4):446–61.

    Article  PubMed  Google Scholar 

  17. Chong GT, Lee RK. Glaucoma versus red disease: imaging and glaucoma diagnosis. Curr Opin Ophthalmol. 2012;23(2):79–88.

    Article  PubMed  Google Scholar 

  18. Wahl J, Barleon L, Morfeld P, Lichtmess A, Haas-Brahler S, Pfeiffer N. The Evonik-Mainz Eye Care-Study (EMECS): development of an expert system for glaucoma risk detection in a working population. PLoS One. 2016;11(8):e0158824.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Muhammad H, Fuchs TJ, De Cuir N, De Moraes CG, Blumberg DM, Liebmann JM, Ritch R, Hood DC. Hybrid deep learning on single wide-field optical coherence tomography scans accurately classifies glaucoma suspects. J Glaucoma. 2017;26(12):1086–94.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hagman J. Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better? Acta Ophthalmol. 2013;91(3):1–47.

    Article  PubMed  Google Scholar 

  21. Lorenz K, Wolfram C, Breitscheidel L, Shlaen M, Verboven Y, Pfeiffer N. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany. Graefes Arch Clin Exp Ophthalmol. 2013;251(8):2019–28.

    Article  PubMed  Google Scholar 

  22. Traverso CE, Walt JG, Kelly SP, Hommer AH, Bron AM, Denis P, Nordmann JP, Renard JP, Bayer A, Grehn F, Pfeiffer N, Cedrone C, Gandolfi S, Orzalesi N, Nucci C, Rossetti L, Azuara-Blanco A, Bagnis A, Hitchings R, Salmon JF, Bricola G, Buchholz PM, Kotak SV, Katz LM, Siegartel LR, Doyle JJ. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol. 2005;89(10):1245–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Heijl A, Alm A, Bengtsson B, Bergstrom A, Calissendorff B, Lindblom B, Linden C, Swedish Ophthalmological Society. The glaucoma guidelines of the Swedish Ophthalmological Society. Acta Ophthalmol Suppl (Oxf). 2012;251:1–40.

    Google Scholar 

  24. Green J, Siddall H, Murdoch I. Learning to live with glaucoma: a qualitative study of diagnosis and the impact of sight loss. Soc Sci Med. 2002;55(2):257–67.

    Article  PubMed  Google Scholar 

  25. Hark L, Waisbourd M, Myers JS, Henderer J, Crews JE, Saaddine JB, Molineaux J, Johnson D, Sembhi H, Stratford S, Suleiman A, Pizzi L, Spaeth GL, Katz LJ. Improving access to eye care among persons at high-risk of glaucoma in philadelphia--design and methodology: the philadelphia glaucoma detection and treatment project. Ophthalmic Epidemiol. 2016;23(2):122–30.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hourihan F, Mitchell P. Factors associated with use of glaucoma medications in a population of older people: The Blue Mountains Eye Study. Aust N Z J Ophthalmol. 1999;27(3–4):176–9.

    Article  CAS  PubMed  Google Scholar 

  27. Dandona L, Dandona R, Mandal P, Srinivas M, John RK, McCarty CA, Rao GN. Angle-closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study. Ophthalmology. 2000;107(9):1710–6.

    Article  CAS  PubMed  Google Scholar 

  28. Dandona R, Dandona L, John RK, McCarty CA, Rao GN. Awareness of eye diseases in an urban population in southern India. Bull World Health Organ. 2001;79(2):96–102.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Vijaya L, George R, Arvind H, Baskaran M, Paul PG, Ramesh SV, Raju P, Kumaramanickavel G, McCarty C. Prevalence of angle-closure disease in a rural southern Indian population. Arch Ophthalmol. 2006;124(3):403–9.

    Article  PubMed  Google Scholar 

  30. Hennis A, Wu SY, Nemesure B, Honkanen R, Leske MC, Barbados Eye Studies Group. Awareness of incident open-angle glaucoma in a population study: the Barbados Eye Studies. Ophthalmology. 2007;114(10):1816–21.

    Article  PubMed  Google Scholar 

  31. WHO. Vision 2020 the right to sight, WHO. 2007. http://www.who.int/blindness/Vision2020_report.pdf?ua=1.

  32. Katibeh M, Ziaei H, Panah E, Moein HR, Hosseini S, Kalantarion M, Eskandari A, Yaseri M. Knowledge and awareness of age related eye diseases: a population-based survey. J Ophthalmic Vis Res. 2014;9(2):223–31.

    PubMed  PubMed Central  Google Scholar 

  33. Lau JT, Lee V, Fan D, Lau M, Michon J. Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population. Br J Ophthalmol. 2002;86(10):1080–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Thapa SS, Berg RV, Khanal S, Paudyal I, Pandey P, Maharjan N, Twyana SN, Paudyal G, Gurung R, Ruit S, Rens GH. Prevalence of visual impairment, cataract surgery and awareness of cataract and glaucoma in Bhaktapur district of Nepal: the Bhaktapur Glaucoma Study. BMC Ophthalmol. 2011;11:2.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Pfeiffer N, Krieglstein GK, Wellek S. Knowledge about glaucoma in the unselected population: a German survey. J Glaucoma. 2002;11(5):458–63.

    Article  PubMed  Google Scholar 

  36. Vad betyder ordet Glaukom?. Ögontrycket, Svenska Glaukomförbundet. 2010.

    Google Scholar 

  37. Dugast P, Thiboust P, Blumen-Ohana E, Nordmann JP. Is there a need for a therapeutic education with patients suffering with open-angle glaucoma? Preliminary inquiry regarding knowledge and patient adherence. J Fr Ophtalmol. 2016;39(6):527–34.

    Article  CAS  PubMed  Google Scholar 

  38. Kowing D, Messer D, Slagle S, Wasik A, V-POAG Study Group. Programs to optimize adherence in glaucoma. Optometry. 2010;81(7):339–50.

    Article  PubMed  Google Scholar 

  39. Leydhecker W, Akiyama K, Neumann HG. Intraocular pressure in normal human eyes. Klin Monbl Augenheilkd Augenarztl Fortbild. 1958;133(5):662–70.

    CAS  PubMed  Google Scholar 

  40. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714–20; discussion 829-730.

    Article  PubMed  Google Scholar 

  41. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–13; discussion 829-730.

    Article  PubMed  Google Scholar 

  42. Prum BE Jr, Herndon LW Jr, Moroi SE, Mansberger SL, Stein JD, Lim MC, Rosenberg LF, Gedde SJ, Williams RD. Primary angle closure preferred practice pattern((R)) guidelines. Ophthalmology. 2016;123(1):P1–P40.

    Article  PubMed  Google Scholar 

  43. Tuulonen A, Airaksinen PJ, Erola E, Forsman E, Friberg K, Kaila M, Klemetti A, Makela M, Oskala P, Puska P, Suoranta L, Teir H, Uusitalo H, Vainio-Jylha E, Vuori ML. The Finnish evidence-based guideline for open-angle glaucoma. Acta Ophthalmol Scand. 2003;81(1):3–18.

    Article  CAS  PubMed  Google Scholar 

  44. Odberg T, Jakobsen JE, Hultgren SJ, Halseide R. The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire. Acta Ophthalmol Scand. 2001;79(2):116–20.

    Article  CAS  PubMed  Google Scholar 

  45. Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, Evans SJ, Doyle JJ. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141(1):24–30.

    Article  PubMed  Google Scholar 

  46. Peters D, Heijl A, Brenner L, Bengtsson B. Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up. Acta Ophthalmol. 2015;93(8):745–52.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Peters D, Bengtsson B, Heijl A. Factors associated with lifetime risk of open-angle glaucoma blindness. Acta Ophthalmol. 2014;92(5):421–5.

    Article  PubMed  Google Scholar 

  48. NEI. 2010 U.S. Age-Specific Prevalence Rates for Glaucoma by Age and Race/Ethnicity. https://nei.nih.gov/eyedata/glaucoma (2010).

  49. Norin O, Enström J, de Gosson de Varennes S. Beteende och behov hos personer i kontakt med vården. Website of Sveriges Kommuner och Landstning: https://skl.se/download/18.5e588ed415aa6ecabde9f48f/1489484509965/Beteenden%20och%20behov%20hos%20personer%20i%20kontakt%20med%20v%C3%A5rden.pdf (2017).

  50. European glaucoma society terminology and guidelines for glaucoma, 4th edition - Chapter 3: treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 treatment principles and options. Br J Ophthalmol. 2017;101(6):130–95.

    Google Scholar 

  51. Kalouda P, Keskini C, Anastasopoulos E, Topouzis F. Achievements and limits of current medical therapy of glaucoma. Dev Ophthalmol. 2017;59:1–14.

    Article  PubMed  Google Scholar 

  52. Matsuura M, Hirasawa K, Hirasawa H, Yanagisawa M, Murata H, Mayama C, Asaoka R. Developing an item bank to measure quality of life in individuals with glaucoma, and the results of the interview with patients: the effect of visual function, visual field progression rate, medical, and surgical treatments on quality of life. J Glaucoma. 2017;26(2):e64–73.

    PubMed  Google Scholar 

  53. Williams AM, Muir KW, Rosdahl JA. Readability of patient education materials in ophthalmology: a single-institution study and systematic review. BMC Ophthalmol. 2016;16:133.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Fukuchi T, Yoshino T, Sawada H, Seki M, Togano T, Tanaka T, Ueda J, Abe H. The relationship between the mean deviation slope and follow-up intraocular pressure in open-angle glaucoma patients. J Glaucoma. 2013;22(9):689–97.

    Article  PubMed  Google Scholar 

  55. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–79.

    Article  PubMed  Google Scholar 

  56. Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, Caprioli J, Advanced Glaucoma Intervention Study. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111(9):1627–35.

    Article  PubMed  Google Scholar 

  57. Clement CI, Bhartiya S, Shaarawy T. New perspectives on target intraocular pressure. Surv Ophthalmol. 2014;59(6):615–26.

    Article  PubMed  Google Scholar 

  58. Chen E, Querat L, Akerstedt C. Self-tonometry as a complement in the investigation of glaucoma patients. Acta Ophthalmol. 2016;94(8):788–92.

    Article  PubMed  Google Scholar 

  59. Querat L, Chen E. Monitoring daily intraocular pressure fluctuations with self-tonometry in healthy subjects. Acta Ophthalmol. 2017;95(5):525–9.

    Article  PubMed  Google Scholar 

  60. Jampel HD. Target pressure in glaucoma therapy. J Glaucoma. 1997;6(2):133–8.

    Article  CAS  PubMed  Google Scholar 

  61. Zeyen T. Target pressures in glaucoma. Bull Soc Belge Ophtalmol. 1999;274:61–5.

    CAS  PubMed  Google Scholar 

  62. Stalmans I, Sunaric Megevand G, Cordeiro MF, Hommer A, Rossetti L, Goni F, Heijl A, Bron A. Preservative-free treatment in glaucoma: who, when, and why. Eur J Ophthalmol. 2013;23(4):518–25.

    Article  PubMed  Google Scholar 

  63. Tuulonen A, Kataja M, Syvanen U, Miettunen S, Uusitalo H. Right services to right patients at right time in right setting in Tays Eye Centre. Acta Ophthalmol. 2016;94(7):730–5.

    Article  PubMed  Google Scholar 

  64. Nordmann JP, Auzanneau N, Ricard S, Berdeaux G. Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes. 2003;1:75.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Tuulonen A. Is more always better? Acta Ophthalmol Scand. 2004;82(4):377–9.

    Article  PubMed  Google Scholar 

  66. Lee BW, Murakami Y, Duncan MT, Kao AA, Huang JY, Lin S, Singh K. Patient-related and system-related barriers to glaucoma follow-up in a county hospital population. Invest Ophthalmol Vis Sci. 2013;54(10):6542–8.

    Article  PubMed  Google Scholar 

  67. Gott bemötande av vården där Stockholmare känner sig mest trygga med sin ögonsjukvård. Ögontrycket, Svenska Glaukomförbundet. 2016.

    Google Scholar 

  68. Ekstrom C. Prevalence of open-angle glaucoma in central Sweden. The Tierp Glaucoma Survey. Acta Ophthalmol Scand. 1996;74(2):107–12.

    Article  CAS  PubMed  Google Scholar 

  69. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80(5):389–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Ramakrishnan R, Nirmalan PK, Krishnadas R, Thulasiraj RD, Tielsch JM, Katz J, Friedman DS, Robin AL. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology. 2003;110(8):1484–90.

    Article  CAS  PubMed  Google Scholar 

  71. Vijaya L, George R, Arvind H, Baskaran M, Raju P, Ramesh SV, Paul PG, Kumaramanickavel G, McCarty C. Prevalence and causes of blindness in the rural population of the Chennai Glaucoma Study. Br J Ophthalmol. 2006;90(4):407–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Abu Hussein NB, Eissa IM, Abdel-Kader AA. Analysis of factors affecting patients’ compliance to topical antiglaucoma medications in Egypt as a developing country model. J Ophthalmol. 2015;2015:234157.

    PubMed  PubMed Central  Google Scholar 

  73. Rotchford AP, Murphy KM. Compliance with timolol treatment in glaucoma. Eye (Lond). 1998;12(Pt 2):234–6.

    Article  Google Scholar 

  74. Schwartz GF. Compliance and persistency in glaucoma follow-up treatment. Curr Opin Ophthalmol. 2005;16(2):114–21.

    Article  PubMed  Google Scholar 

  75. Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11 Suppl):S30–6.

    Article  PubMed  Google Scholar 

  76. Vanelli M, Pedan A, Liu N, Hoar J, Messier D, Kiarsis K. The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses. Clin Ther. 2009;31(11):2628–52.

    Article  PubMed  Google Scholar 

  77. Hwang DK, Liu CJ, Pu CY, Chou YJ, Chou P. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan. JAMA Ophthalmol. 2014;132(12):1446–52.

    Article  PubMed  Google Scholar 

  78. Lusthaus JA, Goldberg I. Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma. Expert Opin Investig Drugs. 2016;25(10):1201–8.

    Article  CAS  PubMed  Google Scholar 

  79. Reardon G, Schwartz GF, Mozaffari E. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study. Clin Ther. 2003;25(4):1172–85.

    Article  CAS  PubMed  Google Scholar 

  80. Yousuf SJ, Jones LS. Adherence to topical glaucoma medication during hospitalization. J Glaucoma. 2011;20(9):573–6.

    Article  PubMed  Google Scholar 

  81. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126(4):498–505.

    Google Scholar 

  82. Norell SE, Granstrom PA, Wassen R. A medication monitor and fluorescein technique designed to study medication behaviour. Acta Ophthalmol (Copenh). 1980;58(3):459–67.

    Article  CAS  Google Scholar 

  83. Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N, Avorn J. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993;83(5):711–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101(5):515–23.

    Article  CAS  PubMed  Google Scholar 

  85. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140(4):598–606.

    Article  PubMed  Google Scholar 

  86. Olthoff CM, Hoevenaars JG, van den Borne BW, Webers CA, Schouten JS. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):235–43.

    Article  PubMed  Google Scholar 

  87. Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112(6):953–61.

    Article  PubMed  Google Scholar 

  88. Schwartz GF, Reardon G, Mozaffari E. Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am J Ophthalmol. 2004;137(1 Suppl):S13–6.

    Article  CAS  PubMed  Google Scholar 

  89. Deokule S, Sadiq S, Shah S. Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms. Ophthalmic Physiol Opt. 2004;24(1):9–15.

    Article  PubMed  Google Scholar 

  90. Mehari T, Giorgis AT, Shibeshi W. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia. BMC Ophthalmol. 2016;16:131.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Movahedinejad T, Adib-Hajbaghery M. Adherence to treatment in patients with open-angle glaucoma and its related factors. Electron Physician. 2016;8(9):2954–61.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009;116(12):2286–93.

    Article  PubMed  Google Scholar 

  93. Hahn SR. Patient-centered communication to assess and enhance patient adherence to glaucoma medication. Ophthalmology. 2009;116(11 Suppl):S37–42.

    Article  PubMed  Google Scholar 

  94. Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12(5):393–8.

    Article  PubMed  Google Scholar 

  95. Chawla A, McGalliard JN, Batterbury M. Use of eyedrops in glaucoma: how can we help to reduce non-compliance? Acta Ophthalmol Scand. 2007;85(4):464.

    Article  PubMed  Google Scholar 

  96. Tsai JC. Medication adherence in glaucoma: approaches for optimizing patient compliance. Curr Opin Ophthalmol. 2006;17(2):190–5.

    PubMed  Google Scholar 

  97. Tsai JH, Derby E, Holland EJ, Khatana AK. Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea. 2006;25(5):530–2.

    Article  PubMed  Google Scholar 

  98. Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113(3):431–6.

    Article  PubMed  Google Scholar 

  99. Ngan R, Lam DL, Mudumbai RC, Chen PP. Risk factors for noncompliance with follow-up among normal-tension glaucoma suspects. Am J Ophthalmol. 2007;144(2):310–1.

    Article  PubMed  Google Scholar 

  100. Friedman DS, Hahn SR, Gelb L, Tan J, Shah SN, Kim EE, Zimmerman TJ, Quigley HA. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology. 2008;115(8):1320–27, 1327 e1321–1323.

    Article  PubMed  Google Scholar 

  101. Budenz DL. A clinician’s guide to the assessment and management of nonadherence in glaucoma. Ophthalmology. 2009;116(11 Suppl):S43–7.

    Article  PubMed  Google Scholar 

  102. Tatham AJ, Sarodia U, Gatrad F, Awan A. Eye drop instillation technique in patients with glaucoma. Eye (Lond). 2013;27(11):1293–8.

    Article  CAS  Google Scholar 

  103. Schwartz GF, Hollander DA, Williams JM. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension. Curr Med Res Opin. 2013;29(11):1515–22.

    Article  PubMed  Google Scholar 

  104. Dietlein TS, Jordan JF, Luke C, Schild A, Dinslage S, Krieglstein GK. Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients. Acta Ophthalmol. 2008;86(8):856–9.

    Article  PubMed  Google Scholar 

  105. Kholdebarin R, Campbell RJ, Jin YP, Buys YM. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol. 2008;43(4):454–61.

    Article  PubMed  Google Scholar 

  106. Mohindroo C, Ichhpujani P, Kumar S. How ‘Drug Aware’ are our glaucoma patients? J Curr Glaucoma Pract. 2015;9(2):33–7.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Linden C, Bengtsson B, Alm A, Calissendorff B, Eckerlund I, Heijl A. Glaucoma management in Sweden -- results from a nationwide survey. Acta Ophthalmol. 2013;91(1):20–4.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Friedman DS, Cramer J, Quigley H. A more proactive approach is needed in glaucoma care. Arch Ophthalmol. 2005;123(8):1134–5.

    Article  PubMed  Google Scholar 

  109. Friedman DS, Hahn SR, Quigley HA, Kotak S, Kim E, Onofrey M, Eagan C, Mardekian J. Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice. Ophthalmology. 2009;116(12):2277–85, e2271–2273.

    Article  PubMed  Google Scholar 

  110. Leske MC, Heijl A, Hyman L, Bengtsson B, Komaroff E. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol. 2004;15(2):102–6.

    Article  PubMed  Google Scholar 

  111. Stewart WC, Kolker AE, Sharpe ED, Day DG, Konstas AG, Hollo G, Astakhov YS, Teus MA, Stewart JA. Long-term progression at individual mean intraocular pressure levels in primary open-angle and exfoliative glaucoma. Eur J Ophthalmol. 2008;18(5):765–70.

    Article  CAS  PubMed  Google Scholar 

  112. Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE, Canadian Glaucoma Study Group. Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma. Arch Ophthalmol. 2008;126(8):1030–6.

    Article  PubMed  Google Scholar 

  113. Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, Azuara-Blanco A, Bourne RR, Broadway DC, Cunliffe IA, Diamond JP, Fraser SG, Ho TA, Martin KR, McNaught AI, Negi A, Patel K, Russell RA, Shah A, Spry PG, Suzuki K, White ET, Wormald RP, Xing W, Zeyen TG. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385(9975):1295–304.

    Article  CAS  PubMed  Google Scholar 

  114. Heijl A, Buchholz P, Norrgren G, Bengtsson B. Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol. 2013;91(5):406–12.

    Article  PubMed  Google Scholar 

  115. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48–56.

    Article  PubMed  Google Scholar 

  116. Miglior S, Torri V, Zeyen T, Pfeiffer N, Vaz JC, Adamsons I, E. Group. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study. Am J Ophthalmol. 2007;144(2):266–75.

    Article  PubMed  Google Scholar 

  117. Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145(2):343–53.

    Article  PubMed  Google Scholar 

  118. Rossetti L, Goni F, Denis P, Bengtsson B, Martinez A, Heijl A. Focusing on glaucoma progression and the clinical importance of progression rate measurement: a review. Eye (Lond). 2010;24(Suppl 1):S1–7.

    Article  Google Scholar 

  119. Harju M. Intraocular pressure and progression in exfoliative eyes with ocular hypertension or glaucoma. Acta Ophthalmol Scand. 2000;78(6):699–702.

    Article  CAS  PubMed  Google Scholar 

  120. Heijl A, Bengtsson B, Hyman L, Leske MC, Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma. Ophthalmology. 2009;116(12):2271–6.

    Article  PubMed  Google Scholar 

  121. Konstas AG, Hollo G, Astakhov YS, Teus MA, Akopov EL, Jenkins JN, Stewart WC. Factors associated with long-term progression or stability in exfoliation glaucoma. Arch Ophthalmol. 2004;122(1):29–33.

    Article  PubMed  Google Scholar 

  122. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z, EMGT Group. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(11):1965–72.

    Article  PubMed  Google Scholar 

  123. Broman AT, Quigley HA, West SK, Katz J, Munoz B, Bandeen-Roche K, Tielsch JM, Friedman DS, Crowston J, Taylor HR, Varma R, Leske MC, Bengtsson B, Heijl A, He M, Foster PJ. Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci. 2008;49(1):66–76.

    Article  PubMed  Google Scholar 

  124. Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B, B. E. S. Group. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115(1):85–93.

    Article  PubMed  Google Scholar 

  125. Prata TS, De Moraes CG, Teng CC, Tello C, Ritch R, Liebmann JM. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage. Ophthalmology. 2010;117(1):24–9.

    Article  PubMed  Google Scholar 

  126. Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology. 2000;107(7):1287–93.

    Article  CAS  PubMed  Google Scholar 

  127. Chung HS, Harris A, Evans DW, Kagemann L, Garzozi HJ, Martin B. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43(Suppl 1):S43–50.

    Article  PubMed  Google Scholar 

  128. Jurgens C, Grossjohann R, Tost F. Distribution of mean, systolic and diastolic ocular perfusion pressure in telemedical homemonitoring of glaucoma patients. Ophthalmic Res. 2012;48(4):208–11.

    Article  PubMed  Google Scholar 

  129. McGlynn MM, Ehrlich JR, Marlow ED, Chee RI, Silva FQ, Van Tassel SH, Radcliffe NM. Association of blood and ocular perfusion pressure with structural glaucomatous progression by flicker chronoscopy. Br J Ophthalmol. 2013;97(12):1569–73.

    Article  PubMed  Google Scholar 

  130. Okumura Y, Yuki K, Tsubota K. Low diastolic blood pressure is associated with the progression of normal-tension glaucoma. Ophthalmologica. 2012;228(1):36–41.

    Article  PubMed  Google Scholar 

  131. Ramdas WD, Wolfs RC, Hofman A, de Jong PT, Vingerling JR, Jansonius NM. Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study. Invest Ophthalmol Vis Sci. 2011;52(9):6875–81.

    Article  PubMed  Google Scholar 

  132. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol. 1995;113(2):216–21.

    Article  CAS  PubMed  Google Scholar 

  133. Bengtsson B, Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2005;243(6):513–8.

    Article  PubMed  Google Scholar 

  134. Bengtsson B, Leske MC, Hyman L, Heijl A, Early Manifest Glaucoma Trial Group. Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114(2):205–9.

    Article  PubMed  Google Scholar 

  135. Caprioli J. Intraocular pressure fluctuation: an independent risk factor for glaucoma? Arch Ophthalmol. 2007;125(8):1124–5.

    Article  PubMed  Google Scholar 

  136. Caprioli J, Coleman A. Pressure fluctuation. Ophthalmology. 2009;116(4):817.

    Article  PubMed  Google Scholar 

  137. Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology. 2008;115(7):1123–29, e1123.

    Article  PubMed  Google Scholar 

  138. De Moraes CG, Juthani VJ, Liebmann JM, Teng CC, Tello C, Susanna R Jr, Ritch R. Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol. 2011;129(5):562–8.

    Article  PubMed  Google Scholar 

  139. Hong S, Seong GJ, Hong YJ. Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch Ophthalmol. 2007;125(8):1010–3.

    Article  PubMed  Google Scholar 

  140. Nouri-Mahdavi K, Medeiros FA, Weinreb RN. Fluctuation of intraocular pressure as a predictor of visual field progression. Arch Ophthalmol. 2008;126(8):1168–69; author reply 1169–1170.

    Article  PubMed  Google Scholar 

  141. Borger PH, van Leeuwen R, Hulsman CA, Wolfs RC, van der Kuip DA, Hofman A, de Jong PT. Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study. Ophthalmology. 2003;110(7):1292–6.

    Article  PubMed  Google Scholar 

  142. Klein BE, Klein R, Meuer SM, Goetz LA. Migraine headache and its association with open-angle glaucoma: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1993;34(10):3024–7.

    CAS  PubMed  Google Scholar 

  143. Lee AJ, Wang JJ, Kifley A, Mitchell P. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Ophthalmology. 2006;113(7):1069–76.

    Article  PubMed  Google Scholar 

  144. Wu SY, Nemesure B, Hennis A, Schachat AP, Hyman L, Leske MC, Barbados Eye Studies Group. Open-angle glaucoma and mortality: the Barbados Eye Studies. Arch Ophthalmol. 2008;126(3):365–70.

    Article  PubMed  Google Scholar 

  145. Knight OJ, Chang RT, Feuer WJ, Budenz DL. Comparison of retinal nerve fiber layer measurements using time domain and spectral domain optical coherent tomography. Ophthalmology. 2009;116(7):1271–7.

    Article  PubMed  Google Scholar 

  146. Zhang X, Dastiridou A, Francis BA, Tan O, Varma R, Greenfield DS, Schuman JS, Huang D, Advanced Imaging for Glaucoma Study Group. Comparison of glaucoma progression detection by optical coherence tomography and visual field. Am J Ophthalmol. 2017;184:63–74.

    Article  PubMed  PubMed Central  Google Scholar 

  147. Prager AJ, Hood DC, Liebmann JM, De Moraes CG, Al-Aswad LA, Yu Q, Cioffi GA, Blumberg DM. Association of glaucoma-related, optical coherence tomography-measured macular damage with vision-related quality of life. JAMA Ophthalmol. 2017;135(7):783–8.

    Article  PubMed  PubMed Central  Google Scholar 

  148. Blumberg DM, De Moraes CG, Prager AJ, Yu Q, Al-Aswad L, Cioffi GA, Liebmann JM, Hood DC. Association between undetected 10-2 visual field damage and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol. 2017;135(7):742–7.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Hong J, Xu J, Wei A, Deng SX, Cui X, Yu X, Sun X. A new tonometer--the Corvis ST tonometer: clinical comparison with noncontact and Goldmann applanation tonometers. Invest Ophthalmol Vis Sci. 2013;54(1):659–65.

    Article  PubMed  Google Scholar 

  150. Kotecha A, White E, Schlottmann PG, Garway-Heath DF. Intraocular pressure measurement precision with the Goldmann applanation, dynamic contour, and ocular response analyzer tonometers. Ophthalmology. 2010;117(4):730–7.

    Article  PubMed  Google Scholar 

  151. Lee YG, Kim JH, Kim NR, Kim CY, Lee ES. Comparison between tonopachy and other tonometric and pachymetric devices. Optom Vis Sci. 2011;88(7):843–9.

    Article  PubMed  Google Scholar 

  152. Nakao Y, Kiuchi Y, Okimoto S. A comparison of the corrected intraocular pressure obtained by the corvis ST and Reichert 7CR tonometers in glaucoma patients. PLoS One. 2017;12(1):e0170206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  153. WHO. WHOQOL: measuring quality of life. World Health Organization. http://www.who.int/healthinfo/survey/whoqol-qualityoflife/en/.

  154. van der Krieke L, Blaauw FJ, Emerencia AC, Schenk HM, Slaets JP, Bos EH, de Jonge P, Jeronimus BF. Temporal dynamics of health and well-being: a crowdsourcing approach to momentary assessments and automated generation of personalized feedback. Psychosom Med. 2017;79(2):213–23.

    PubMed  Google Scholar 

  155. Fenwick EK, Ong PG, Man REK, Sabanayagam C, Cheng CY, Wong TY, Lamoureux EL. Vision impairment and major eye diseases reduce vision-specific emotional well-being in a Chinese population. Br J Ophthalmol. 2017;101(5):686–90.

    Article  PubMed  Google Scholar 

  156. McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R, Los Angeles Latino Eye Study Group. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008;115(6):941–48 e941.

    Article  PubMed  Google Scholar 

  157. Nelson P, Aspinall P, Papasouliotis O, Worton B, O’Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma. 2003;12(2):139–50.

    Article  PubMed  Google Scholar 

  158. Quaranta L, Riva I, Gerardi C, Oddone F, Floriano I, Konstas AG. Quality of life in glaucoma: a review of the literature. Adv Ther. 2016;33(6):959–81.

    Article  PubMed  PubMed Central  Google Scholar 

  159. Wilson MR, Coleman AL, Yu F, Bing EG, Sasaki IF, Berlin K, Winters J, Lai A. Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology. 1998;105(11):2112–6.

    Article  CAS  PubMed  Google Scholar 

  160. Viswanathan AC, McNaught AI, Poinoosawmy D, Fontana L, Crabb DP, Fitzke FW, Hitchings RA. Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol. 1999;117(4):450–4.

    Article  CAS  PubMed  Google Scholar 

  161. Burton R, Crabb DP, Smith ND, Glen FC, Garway-Heath DF. Glaucoma and reading: exploring the effects of contrast lowering of text. Optom Vis Sci. 2012;89(9):1282–7.

    Article  PubMed  Google Scholar 

  162. Ramulu PY, West SK, Munoz B, Jampel HD, Friedman DS. Glaucoma and reading speed: the Salisbury Eye Evaluation project. Arch Ophthalmol. 2009;127(1):82–7.

    Article  PubMed  PubMed Central  Google Scholar 

  163. Murata N, Miyamoto D, Togano T, Fukuchi T. Evaluating silent reading performance with an eye tracking system in patients with glaucoma. PLoS One. 2017;12(1):e0170230.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  164. Haymes SA, Leblanc RP, Nicolela MT, Chiasson LA, Chauhan BC. Risk of falls and motor vehicle collisions in glaucoma. Invest Ophthalmol Vis Sci. 2007;48(3):1149–55.

    Article  PubMed  Google Scholar 

  165. Janz NK, Musch DC, Gillespie BW, Wren PA, Niziol LM, Collaborative Initial Glaucoma Treatment Study (CIGTS) Investigators. Evaluating clinical change and visual function concerns in drivers and nondrivers with glaucoma. Invest Ophthalmol Vis Sci. 2009;50(4):1718–25.

    Article  PubMed  Google Scholar 

  166. Stryker JE, Beck AD, Primo SA, Echt KV, Bundy L, Pretorius GC, Glanz K. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma. 2010;19(1):66–72.

    Article  PubMed  PubMed Central  Google Scholar 

  167. Asrani S, Chatterjee A, Wallace DK, Santiago-Turla C, Stinnett S. Evaluation of the ICare rebound tonometer as a home intraocular pressure monitoring device. J Glaucoma. 2011;20(2):74–9.

    Article  PubMed  Google Scholar 

  168. Rosentreter A, Jablonski KS, Mellein AC, Gaki S, Hueber A, Dietlein TS. A new rebound tonometer for home monitoring of intraocular pressure. Graefes Arch Clin Exp Ophthalmol. 2011;249(11):1713–9.

    Article  PubMed  Google Scholar 

  169. Sood V, Ramanathan US. Self-monitoring of intraocular pressure outside of normal office hours using rebound tonometry: initial clinical experience in patients with normal tension glaucoma. J Glaucoma. 2016;25(10):807–11.

    Article  PubMed  Google Scholar 

  170. Termuhlen J, Mihailovic N, Alnawaiseh M, Dietlein TS, Rosentreter A. Accuracy of measurements with the iCare HOME rebound tonometer. J Glaucoma. 2016;25(6):533–8.

    Article  PubMed  Google Scholar 

  171. Flemmons MS, Hsiao YC, Dzau J, Asrani S, Jones S, Freedman SF. Home tonometry for management of pediatric glaucoma. Am J Ophthalmol. 2011;152(3):470–8. e472

    Article  PubMed  Google Scholar 

  172. Gandhi NG, Jones SK, Freedman SF. Icare ONE home tonometry in children with and without known glaucoma. J Glaucoma. 2016;25(2):e66–9.

    Article  PubMed  Google Scholar 

  173. Hsiao YC, Dzau JR, Flemmons MS, Asrani S, Jones S, Freedman SF. Home assessment of diurnal intraocular pressure in healthy children using the Icare rebound tonometer. J AAPOS. 2012;16(1):58–60.

    Article  PubMed  Google Scholar 

  174. Lowry EA, Hou J, Hennein L, Chang RT, Lin S, Keenan J, Wang SK, Ianchulev S, Pasquale LR, Han Y. Comparison of peristat online perimetry with the humphrey perimetry in a clinic-based setting. Transl Vis Sci Technol. 2016;5(4):4.

    Article  PubMed  PubMed Central  Google Scholar 

  175. Matsumoto C, Yamao S, Nomoto H, Takada S, Okuyama S, Kimura S, Yamanaka K, Aihara M, Shimomura Y. Visual field testing with head-mounted perimeter ‘imo’. PLoS One. 2016;11(8):e0161974.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  176. Anderson AJ, Bedggood PA, George Kong YX, Martin KR, Vingrys AJ. Can home monitoring allow earlier detection of rapid visual field progression in glaucoma? Ophthalmology. 2017;124(12):1735–42.

    Article  PubMed  Google Scholar 

  177. WHO. Vision impairment and blindness. World Health Organization. 2017. http://www.who.int/mediacentre/factsheets/fs282/en/.

  178. Baker RS, Bazargan M, Bazargan-Hejazi S, Calderon JL. Access to vision care in an urban low-income multiethnic population. Ophthalmic Epidemiol. 2005;12(1):1–12.

    Article  PubMed  Google Scholar 

  179. Holahan J, Cook A. Changes in economic conditions and health insurance coverage, 2000–2004. Health Aff (Millwood) 2005;Suppl Web Exclusives:W5-498–508.

    Google Scholar 

  180. Zhang X, Andersen R, Saaddine JB, Beckles GL, Duenas MR, Lee PP. Measuring access to eye care: a public health perspective. Ophthalmic Epidemiol. 2008;15(6):418–25.

    Article  PubMed  Google Scholar 

  181. Glen FC, Crabb DP. Living with glaucoma: a qualitative study of functional implications and patients’ coping behaviours. BMC Ophthalmol. 2015;15:128.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  182. Ramulu P. Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol. 2009;20(2):92–8.

    Article  PubMed  PubMed Central  Google Scholar 

  183. Goldberg I, Clement CI, Chiang TH, Walt JG, Lee LJ, Graham S, Healey PR. Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire. J Glaucoma. 2009;18(1):6–12.

    Article  PubMed  Google Scholar 

  184. Nassiri N, Mehravaran S, Nouri-Mahdavi K, Coleman AL. National Eye Institute Visual Function Questionnaire: usefulness in glaucoma. Optom Vis Sci. 2013;90(8):745–53.

    Article  PubMed  Google Scholar 

  185. Popescu ML, Boisjoly H, Schmaltz H, Kergoat MJ, Rousseau J, Moghadaszadeh S, Djafari F, Freeman EE. Age-related eye disease and mobility limitations in older adults. Invest Ophthalmol Vis Sci. 2011;52(10):7168–74.

    Article  PubMed  Google Scholar 

  186. Algvere PV, Jahnberg P, Textorius O. The Swedish retinal detachment Register. I. A database for epidemiological and clinical studies. Graefes Arch Clin Exp Ophthalmol. 1999;237(2):137–44.

    Article  CAS  PubMed  Google Scholar 

  187. Artzen D, Lundstrom M, Behndig A, Stenevi U, Lydahl E, Montan P. Capsule complication during cataract surgery: case-control study of preoperative and intraoperative risk factors: Swedish Capsule Rupture Study Group report 2. J Cataract Refract Surg. 2009;35(10):1688–93.

    Article  PubMed  Google Scholar 

  188. Behndig A, Montan P, Stenevi U, Kugelberg M, Lundstrom M. One million cataract surgeries: Swedish National Cataract Register 1992–2009. J Cataract Refract Surg. 2011;37(8):1539–45.

    Article  PubMed  Google Scholar 

  189. Clark A, Ng JQ, Morlet N, Semmens JB. Big data and ophthalmic research. Surv Ophthalmol. 2016;61(4):443–65.

    Article  PubMed  Google Scholar 

  190. Tuulonen A, Azuara-Blanco A. Cost-effectiveness. Ophthalmology. 2009;116(1):166–7.

    Article  PubMed  Google Scholar 

  191. Tuulonen A. Challenges of glaucoma care – high volume, high quality, low cost. Acta Ophthalmol. 2013;91(1):3–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glaucoma Service, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden

    Enping Chen, Behrad Samadi & Laurence Quérat

Authors
  1. Enping Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Behrad Samadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laurence Quérat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Enping Chen .

Editor information

Editors and Affiliations

  1. Eye & ENT Hospital, Shanghai Medical College of Fudan University, Shanghai, China

    Xinghuai Sun

  2. Eye & ENT Hospital, Shanghai Medical College of Fudan University, Shanghai, China

    Yi Dai

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chen, E., Samadi, B., Quérat, L. (2019). Patient Management. In: Sun, X., Dai, Y. (eds) Medical Treatment of Glaucoma. Springer, Singapore. https://doi.org/10.1007/978-981-13-2733-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-2733-9_9

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-2732-2

  • Online ISBN: 978-981-13-2733-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation